This segment focuses on designing, manufacturing, and marketing orthopedic reconstructive products, primarily for knee and hip replacements. Research and development efforts are directed towards improving implant longevity, surgical techniques, and patient outcomes. Technologies employed include advanced materials science, biomechanical engineering, and computer-assisted design. The segment addresses osteoarthritis, rheumatoid arthritis, and traumatic injuries, aiming to restore mobility and alleviate pain for patients. Zimmer Biomet holds a strong market position in this area, leveraging its established brand and extensive distribution network. Future opportunities include expanding the use of robotics and personalized implants to enhance surgical precision and patient satisfaction. Regulatory compliance and clinical validation are critical aspects of this segment, ensuring product safety and efficacy.

The S.E.T. segment encompasses a diverse range of products and solutions for sports medicine, biologics, extremities, and trauma-related injuries. Research and development activities focus on developing innovative fixation devices, regenerative therapies, and minimally invasive surgical techniques. Technologies utilized include biologics, such as bone grafts and growth factors, as well as advanced materials for implants and fixation devices. This segment addresses a wide range of conditions, including ligament tears, fractures, and joint instability, with the goal of restoring function and accelerating healing. Zimmer Biomet aims to provide comprehensive solutions for orthopedic surgeons, leveraging its expertise in both surgical and non-surgical interventions. Future opportunities include expanding the use of biologics and regenerative medicine to enhance tissue repair and reduce the need for revision surgeries. Clinical trials and regulatory approvals are essential for bringing new products and therapies to market.

This segment specializes in medical devices and surgical instruments for spine-related conditions. Research and development efforts are focused on developing innovative spinal implants, biologics, and minimally invasive surgical techniques. Technologies employed include advanced materials science, biomechanical engineering, and image-guided surgery. The segment addresses a wide range of spinal disorders, including degenerative disc disease, spinal stenosis, and scoliosis, with the goal of relieving pain, restoring function, and improving quality of life for patients. Zimmer Biomet aims to provide comprehensive solutions for spine surgeons, leveraging its expertise in both surgical and non-surgical interventions. Future opportunities include expanding the use of biologics and regenerative medicine to enhance spinal fusion and reduce the need for revision surgeries. Clinical trials and regulatory approvals are essential for bringing new products and therapies to market.

The Dental segment offers a comprehensive portfolio of dental reconstructive implants, prosthetic solutions, and regenerative products. Research and development activities are directed towards improving implant osseointegration, esthetics, and long-term stability. Technologies employed include advanced materials science, digital dentistry, and guided surgery. This segment addresses tooth loss, periodontal disease, and other oral health issues, aiming to restore function, esthetics, and confidence for patients. Zimmer Biomet aims to provide comprehensive solutions for dental professionals, leveraging its expertise in both surgical and restorative dentistry. Future opportunities include expanding the use of digital technologies and personalized solutions to enhance treatment planning and patient outcomes. Clinical trials and regulatory approvals are essential for ensuring the safety and efficacy of dental implants and related products.